OMDANasdaqServices-Health ServicesFiscal year ends December 31
Omada Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$18.06+0.43 (+2.44%)
Close on Oct 19, 2026
- Market cap
- $1.15B
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$6.85 (−27.50%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Omada Health, Inc. grew revenue 47.6% to $309.76M over the twelve months to Jun 30, 2026. Free cash flow was $22.73M.
Revenue
$309.76M
+47.6% vs. a year earlier
Operating income
-$464.00K
TTM Q2 2026
Free cash flow
$22.73M
TTM Q2 2026
EPS, diluted
-$0.35
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.15B
- P/E ratio
- –
- Price to sales
- 3.73
- Price to book
- 4.57
- Dividend yield
- –
- Free cash flow yield
- 1.97%
Fundamentals
- Revenue
- $309.76M
- Net income
- $4.31M
- EPS, diluted
- -$0.35
- Free cash flow
- $22.73M
- Book value per share
- $3.95
- Diluted shares
- 64M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$309.76M+47.6% YoY
Gross profit
$211.21M+58.9% YoY
Operating income
-$464.00K
Net income
$4.31M
EPS, diluted
–
Free cash flow
$22.73M
Reported periodTrailing twelve months